Find information on Clinical Depression (Major Depressive Disorder, MDD) diagnosis criteria, including ICD-10 and DSM-5 codes for accurate medical coding and billing. Learn about clinical documentation requirements for MDD and Major Depressive Disorder, covering symptoms, assessment, and treatment planning. This resource helps healthcare professionals ensure proper diagnosis coding and comprehensive clinical documentation for patients with Clinical Depression.
Also known as
Depressive episodes
Covers single and recurrent depressive disorders like MDD.
Mood affective disorders
Includes various mood disorders such as bipolar and depression.
Neurotic, stress-related disorders
Includes disorders where depression may be a symptom, like anxiety.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the depression single or recurrent episode?
When to use each related code
| Description |
|---|
| Persistent sadness and loss of interest. |
| Chronic, low-grade depressed mood. |
| Mood disorder with recurrent depressive episodes. |
Coding MDD as unspecified depression (F32.9) without sufficient documentation supporting lack of symptom specifics.
Failing to capture and code co-existing anxiety disorders or other conditions frequently associated with MDD.
Incorrectly coding the severity of MDD (mild, moderate, severe) due to inadequate clinical documentation.
Q: What are the most effective evidence-based treatment strategies for managing treatment-resistant depression (TRD) in adults with comorbid anxiety?
A: Treatment-resistant depression (TRD), particularly in the presence of comorbid anxiety, requires a multifaceted approach. Evidence-based strategies include augmenting first-line antidepressants with other medications like atypical antipsychotics (e.g., aripiprazole, quetiapine), lithium, or triiodothyronine. Non-pharmacological interventions such as repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), and psychotherapy, especially Cognitive Behavioral Therapy (CBT) and interpersonal therapy, have also demonstrated efficacy. Consider implementing a measurement-based care approach to track progress and tailor treatments. Explore how integrating mindfulness-based interventions can further support patients managing TRD and anxiety. For severe cases, collaborative care with a psychiatrist is crucial for comprehensive assessment and personalized treatment plans.
Q: How to differentiate between clinical depression (major depressive disorder) and bereavement, and when to consider pharmacological intervention for prolonged grief in a primary care setting?
A: Differentiating between clinical depression (major depressive disorder or MDD) and bereavement requires careful assessment of symptom duration, intensity, and functional impairment. While sadness, loss of interest, and sleep disturbance can occur in both, bereavement typically involves pangs of grief alongside positive emotions and memories of the deceased. MDD, however, presents with more persistent and pervasive low mood, anhedonia, feelings of worthlessness, and significant impairment in daily functioning. Prolonged grief, lasting beyond 12 months and significantly impacting daily life, may warrant pharmacological intervention. Consider implementing a screening tool like the Prolonged Grief Disorder Scale (PG-13). First-line treatments for complicated grief can include antidepressants like selective serotonin reuptake inhibitors (SSRIs), as they have shown efficacy in managing both depressive and grief symptoms. Learn more about the diagnostic criteria for prolonged grief disorder and appropriate referral pathways for specialized bereavement support.
Patient presents today with symptoms consistent with a diagnosis of Major Depressive Disorder (MDD), also known as Clinical Depression. The patient reports persistent sadness, anhedonia, and feelings of hopelessness for the past six weeks. These symptoms meet the DSM-5 criteria for MDD, impacting the patient's daily functioning and quality of life. Symptoms include depressed mood most of the day, nearly every day, diminished interest or pleasure in all, or almost all, activities, significant weight loss without dieting or weight gain, insomnia or hypersomnia nearly every day, psychomotor agitation or retardation nearly every day, fatigue or loss of energy nearly every day, feelings of worthlessness or excessive or inappropriate guilt, diminished ability to think or concentrate, or indecisiveness, nearly every day, and recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide. The patient denies any history of manic or hypomanic episodes. Current medication reconciliation reveals no contributing medications. Family history is significant for depression in the patient's mother. Differential diagnoses considered included adjustment disorder with depressed mood and bereavement, but the duration and severity of symptoms support the diagnosis of MDD. Treatment plan includes initiation of psychotherapy with Cognitive Behavioral Therapy (CBT) techniques and pharmacotherapy with a selective serotonin reuptake inhibitor (SSRI). Patient education was provided on medication side effects, management strategies for depressive symptoms, and the importance of medication adherence. The patient was also provided with crisis hotline information and encouraged to establish a strong support system. Follow-up appointment scheduled in two weeks to assess treatment response and adjust treatment plan as needed. ICD-10 code F32.9 (Major depressive disorder, single episode, unspecified) assigned. Medical billing codes for evaluation and management (E/M) services will be determined based on time spent and complexity of medical decision making.